ArticleMolecular therapy. Methods & clinical development2015

Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance.

Kristina Blazanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.